FMK-60972-09777
3 vaccinations
6 coded responses
29 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 473 / IN
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Registered in v-safe
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Redness, Itching · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-04-09
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — day 7, dose 1Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-20
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-04-27
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Itching · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-04
Health check-in — day 7, dose 2Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-03
- 2021-06-10
-
2021-07-27
Survey response — 3 months, dose 2MedDRA: Chest pain, Migraine, Post-acute COVID-19 syndrome — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I have had worsening migraines and chest pains. I have post covid syndromeMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-26
-
2022-02-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-03-29
Dose 3 — Pfizer-BioNTech
-
2022-04-27
Survey response — 12 months, dose 2MedDRA: COVID-19, Hypersensitivity, Office visit — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I had an allergic reaction to my booster shot. I'm also being seen by the (b)(6) post Covid clinic due to all problems I've had since having covidMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Survey response — day 28, dose 3MedDRA: Injection site discolouration, Rash, Self-medication, Swelling, Urticaria — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Had swelling, hives, rash from last booster shot. I had to take Benadryl for a week and hydrocortisone cream for over 3 weeks. I still have a large mark from the shotMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Survey response — day 35, dose 3MedDRA: Heavy menstrual bleeding, Polymenorrhoea — Feeling: PoorFree text: My period has been mor frequent and heavy since having my past vaccinationMedDRA releases: 2024-11 · check-in free text available
-
2022-05-10
Survey response — day 42, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: The fatigue is getting worseMedDRA releases: 2024-11 · check-in free text available
- 2022-06-28
- 2022-09-27
-
2023-04-04
Survey response — 12 months, dose 3MedDRA: Back pain, Dyspnoea, Heart rate increased, Migraine, Painful respiration — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-04
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech | |
| 3 | 2022-03-29 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: I have had worsening migraines and chest pains. I have post covid syndrome
Release 11 — day 28, dose 3
Symptoms: Had swelling, hives, rash from last booster shot. I had to take Benadryl for a week and hydrocortisone cream for over 3 weeks. I still have a large mark from the shot
Release 11 — 12 months, dose 2
Symptoms: I had an allergic reaction to my booster shot. I'm also being seen by the (b)(6) post Covid clinic due to all problems I've had since having covid
redacted (b)(6)
Release 11 — day 35, dose 3
Symptoms: My period has been mor frequent and heavy since having my past vaccination
Release 11 — day 42, dose 3
Symptoms: The fatigue is getting worse
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | · | · | ✓ |
| SD | Chest pain | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Injection site discolouration | · | · | ✓ |
| SD | Migraine | ✓ | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Painful respiration | · | · | ✓ |
| SD | Polymenorrhoea | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | ✓ | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Swelling | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release